E163K (p.Glu163Lys) variant of SATB2 (DNA-binding protein SATB2)
E163K (p.Glu163Lys) in SATB2 (DNA-binding protein SATB2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.99 / 1. The record also includes structural context.
E163K (p.Glu163Lys) variant details
- p.Glu163Lys
- NCI-TCGA Cosmic COSV9961
- cosmic curated COSV99611
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.989
- ESM-1b 1.00
- AlphaMissense 0.98
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available